Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
INDUSTRY
×
pembrolizumab
×
Clear all
Filters
3
NCT03715205
2025-08-29
Keynote-593
Merck Sharp & Dohme LLC
Phase 4
Completed
150 enrolled
14 charts
NCT04489888
2025-06-19
MK-3475-B10
Merck Sharp & Dohme LLC
Phase 4
Completed
101 enrolled
14 charts